Arthritis Research & Therapy · 2019 · 63 citations · 33 references
DentistryEndocrinologyImmunologyAutoimmunityImmunoregulationInflammationSalivary FunctionSalivary Gland PathologySalivary Gland PhysiologySalivary GlandsSjogren SyndromeSjögren SyndromeImmunomodulatory EffectsPeripheral Regulatory T CellsSalivary Flow Rate AssessmentSalivary Flow Rate MeasurementSalivary Gland InflammationSalivary Immune RegulationSjögren Syndrome HistopathologyT Follicular Helper Cells
BACKGROUND: Activated T and B cells participate in the development and progression of Sjögren's syndrome (SS). Metformin, a first-line anti-diabetic drug, exerts anti-inflammatory and immunomodulatory effects by activating AMPK. We investigated the therapeutic effect of metformin in non-obese diabetic (NOD)/ShiLtJ mice, an animal model of SS. METHODS: T and B cell differentiation in the peripheral blood and/or spleen was determined by flow cytometry. Serum total IgG, IgG1, and IgG2a levels were determined by enzyme-linked immunosorbent assay. RESULTS: Metformin reduced salivary gland inflammation and restored the salivary flow rate. Moreover, metformin reduced the interleukin (IL)-6, tumor necrosis factor-α, IL-17 mRNA, and protein levels in the salivary glands. Metformin reduced the Th17 and Th1 cell populations and increased the regulatory T cell population in the peripheral blood and spleen and modulated the balance between Tfh and follicular regulatory T cells. In addition, metformin reduced B cell differentiation into germinal center B cells, decreased the serum immunoglobulin G level, and maintained the balance between IL-10- and IL-17-producing B cells. CONCLUSION: Metformin suppresses effector T cells, induces regulatory T cells, and regulates B cell differentiation in an animal model of SS. In addition, metformin ameliorates salivary gland inflammation and hypofunction, suggesting that it has potential for the treatment of SS.
33
Role of AMP-activated protein kinase in mechanism of metformin action
Gaochao Zhou, Robert P. Myers, Ying Li et al. · Journal of Clinical Investigation · 2001 · 5.4K citations
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju, Derek M. Erion, Yasmeen Rahimi et al. · Nature · 2014 · 1.3K citations
The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Greg M. Delgoffe, Thomas P. Kole, Yan Zheng et al. · Immunity · 2009 · 1.3K citations · Full text
The Energy Sensor AMPK Regulates T Cell Metabolic Adaptation and Effector Responses In Vivo
Julianna Blagih, François Coulombe, Emma E. Vincent et al. · Immunity · 2015 · 659 citations · Full text